Related Experiment Videos
Radio-frequency tissue ablation in liver trauma: an experimental study
Evangelos Felekouras1, Michael Kontos, Theodora Pissanou
1First Department of Surgery, University of Athens, Laiko General Hospital, Athens, Greece.
The American Surgeon
|December 14, 2004
Summary
Radio-frequency tissue ablation (RFA) effectively stopped bleeding in severe liver trauma in pigs. This safe method shows promise for treating hepatic injuries, with zero mortality or complications observed.
Area of Science:
- Surgical Innovation
- Hepatobiliary Surgery
- Minimally Invasive Procedures
Background:
- The liver is the most frequently injured intra-abdominal organ, posing significant clinical challenges.
- Effective hemostasis is critical for managing severe hepatic trauma.
- Existing treatments for liver injuries may have limitations.
Purpose of the Study:
- To experimentally evaluate the efficacy and safety of radio-frequency tissue ablation (RFA) for treating severe liver trauma.
- To assess RFA's hemostatic capabilities in grade III and grade III-IV hepatic injuries.
- To compare outcomes of RFA treatment versus untreated controls in a porcine model.
Main Methods:
- Induction of grade III and grade III-IV liver trauma in 10 domestic pigs.
- Application of RFA with cooled tip electrodes to achieve hemostasis at injury sites.
- Histologic and radiologic examination of liver tissues at multiple time points (0, 3, 7, 14, 21 days).
- Inclusion of a control group with untreated liver trauma.
Main Results:
- Complete hemostasis was achieved in all RFA-treated animals.
- Zero mortality and morbidity were observed in the RFA treatment group.
- No abdominal complications (blood, pus, bile) were detected at sacrifice.
- Histology revealed a distinct three-zone lesion pattern around electrode placement.
- Untreated control animals died immediately postoperatively, confirming injury severity.
Conclusions:
- RFA is an efficient and safe hemostatic method for managing severe hepatic trauma (grade III and III-IV).
- The technique demonstrated excellent safety with no observed mortality or morbidity.
- Further clinical investigations are warranted to translate these findings to human application.